Skip to main content
Erschienen in: Cardiovascular Intervention and Therapeutics 2/2018

30.12.2016 | Images in Cardiovascular Intervention

Calcified nodule as an unsolved cause of coronary stent thrombosis in the new-generation drug-eluting stent era

verfasst von: Kazuhiko Yumoto, Tsubasa Kanaya, Shingo Tanaka, Tomoyuki Fukuzawa, Takahiro Watanabe, Hajime Aoki

Erschienen in: Cardiovascular Intervention and Therapeutics | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Excerpt

A 78-year-old man was admitted with sudden onset chest pain presenting as ST-segment elevation myocardial infarction. He had insulin-treated diabetes and underwent hemodialysis for 2 years because of end-stage diabetic nephropathy. Five months previously, he was treated for effort angina. Everolimus-eluting coronary stents were implanted following scoring-balloon dilatation with excellent expansion under intravascular ultrasound (IVUS) guidance for diffuse stenosis with calcified nodules (CN) and platy calcification in the proximal right coronary artery (Fig. 1A, B). He took prasugrel and aspirin regularly. The emergent coronary angiogram showed a thrombus originating from a large filling defect in the proximal in-stent segment with TIMI flow grade 1. Neither stent deformity nor fracture was seen under fluoroscopy. IVUS showed a convex surface with protruding lumpy, superficial calcification accompanied by acoustic shadow, indicating CN. A floating thrombus originated from the proximal segment (Fig. 1C). After aspirating the thrombus, 1.5-mm balloon dilatation restored the coronary flow. The optical coherence tomography scan showed large protruding high-backscattering lesions with signal attenuation characterized by CN. Neither malapposed nor uncovered stent struts were detected  (Fig. 1D). Finally, 4.0-mm scoring-balloon dilatation provided acceptable expansion of the lumen area. The CN treated with new-generation drug-eluting stents (DESs) recurred in the in-stent lumen and caused stent thrombosis. The protruding CN in the stented lumen from underlying previously stented calcified plaque led to stent thrombosis [1]. A stent for CN in patient on hemodialysis barely expands, and implanted stent struts are covered with minimal neointima [2]. The incidence of coronary stent thrombosis has dramatically decreased in the new-generation DES with dual antiplatelet therapy (DAPT) era. Mechanisms of stent thrombosis have been clarified and solved to avoid early discontinuation of DAPT, stent underexpansion, uncovered struts, malapposition, late positive remodeling, and neoatherosclerosis. Although the mechanism of in-stent CN is unclear, implantation of DES for CN may exaggerate the progression of protruding CN as the cause of stent thrombosis, especially in patients on dialysis.
Literatur
1.
Zurück zum Zitat Mori H, Finn AV, Atkinson JB, Lutter C, Narula J, Virmani R. Calcified nodule: an early and late cause of in-stent failure. JACC Cardiovasc Interv. 2016;9:e125–6.CrossRefPubMed Mori H, Finn AV, Atkinson JB, Lutter C, Narula J, Virmani R. Calcified nodule: an early and late cause of in-stent failure. JACC Cardiovasc Interv. 2016;9:e125–6.CrossRefPubMed
2.
Zurück zum Zitat Kawakami R, Hao H, Takagi Y, Fujino A, Tsuchida YA, Imanaka T, et al. Drug-eluting stent implantation on calcified nodule: ex vivo intravascular images and histopathology. JACC Cardiovasc Interv. 2015;8:e127–8.CrossRefPubMed Kawakami R, Hao H, Takagi Y, Fujino A, Tsuchida YA, Imanaka T, et al. Drug-eluting stent implantation on calcified nodule: ex vivo intravascular images and histopathology. JACC Cardiovasc Interv. 2015;8:e127–8.CrossRefPubMed
Metadaten
Titel
Calcified nodule as an unsolved cause of coronary stent thrombosis in the new-generation drug-eluting stent era
verfasst von
Kazuhiko Yumoto
Tsubasa Kanaya
Shingo Tanaka
Tomoyuki Fukuzawa
Takahiro Watanabe
Hajime Aoki
Publikationsdatum
30.12.2016
Verlag
Springer Japan
Erschienen in
Cardiovascular Intervention and Therapeutics / Ausgabe 2/2018
Print ISSN: 1868-4300
Elektronische ISSN: 1868-4297
DOI
https://doi.org/10.1007/s12928-016-0454-5

Weitere Artikel der Ausgabe 2/2018

Cardiovascular Intervention and Therapeutics 2/2018 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.